Rede D’Or São Luiz, through GSH Corp, has acquired full control of Laboratório Integrado de Análises Clínicas (LIAC), enhancing its capabilities in hemotherapeutic services and laboratory analyses.
Target Information
The Rede D’Or São Luiz Group, through its subsidiary GSH Corp Participações S.A., has strategically expanded its presence in the healthcare sector by acquiring the remaining interest in the Laboratório Integrado de Análises Clínicas (LIAC). This acquisition allows GSH to fully consolidate its control over LIAC, further enhancing its capabilities in the fields of blood analysis and hemotherapeutic services. Located in Rio de Janeiro, LIAC specializes in laboratory testing for blood donors, which is a vital component of the hemotherapy services offered by GSH.
Industry Overview in Brazil
The healthcare industry in Brazil is experiencing significant growth, driven by increased demand for specialized medical services and a rising population. In recent years, there has been a marked trend toward consolidation within the sector, as larger healthcare groups seek to strengthen their market positions by acquiring specialized providers. This trend not only improves service offerings but also enhances operational efficiencies.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The Brazilian health market is characterized by diverse service segments, where public and private sectors coexist with varying degrees of access and quality. Large hos
Similar Deals
ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A. → CURA – Centro de Ultrassonografia e Radiologia S.A.
2025
GSH Corp Participações S.A.
invested in
Laboratório Integrado de Análises Clínicas (LIAC)
in 2024
in a Buyout deal